Alexion Pharmaceuticals Inc.
ALXN
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$196.03
7.4% upside
Current Fair Value
7.4% upsideUndervalued by 7.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-937,300,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.75 |
| Beta | 1.26 |
| Outstanding Shares | 220,100,000 |
Return
| Return on Equity | 5.49% |
|---|---|
| Return on Assets | 3.66% |
| Return on Invested Capital | 17.11% |
Valuation & Multiples
| P/E Ratio | 66.36 |
|---|---|
| PEG | 471.99 |
| Price to Sales | 6.52 |
| Price to Book Ratio | 3.26 |
| Enterprise Value to Revenue | -0.15 |
| Enterprise Value to EBIT | -0.32 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -2.7 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alexion Pharmaceuticals Inc.
CEO: Leonard Bell